ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01945775
Brief Title: A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) (EMBRACA)

First Submitted : September 11, 2013
First Submitted that Met QC Criteria : September 16, 2013
First Posted : September 19, 2013 (Estimate)

Results First Submitted : September 5, 2018
Results First Submitted that Met QC Criteria : September 5, 2018
Results First Posted : October 3, 2018

Last Update Submitted that Met QC Criteria : October 2, 2018
Last Update Posted : October 4, 2018